Site hosted by Build your free website today!


MORE evidence the documents on my site are true in saying that inoculations cause corruption in the immune system leading to all autoimmune disease and cancer... (LOOK AT LAST SENTENCE UNDER SAFETY & EFFICACY BELOW...Of course this is true for all vaccines (not just rabies), whether the insert admits it or not....)

Please also listen to my archives interviewing veterinarian Dr Patricia Jordan on May 17 & 24, 2007 on to learn what her research has proven as to how vaccines are killing pets, which are the canary in the coal mine for people....For example, she responds to a caller as to why there is a massive increase in dog bites in this country is because the rabies vaccine is making the dogs rabid!

Reference is "Compendium of Veterinary Products", Tenth Edition, Copyright 2007

Rabies Vaccine (produced by Pfizer)

Killed Virus

For use in dogs, cats, cattle and sheep only

Defensor© 3

PRODUCT DESCRIPTION: Defensor 3 is for vaccination of healthy dogs, cats, cattle, and sheep 3 months of age or older as an aid in preventing rabies. The vaccine is prepared from cell-cultire-grown, chemically inactivated rabies virus which originated from Louis Pasteur's original isolate in 1882. The inactivated virus is formulated with a highly purified adjuvant and is packaged in liquid form.

DISEASE DESCRIPTION: Rabies is a worldwide, high mortality disease affecting mammalian species. Wild animals are common vectors of the disease and the major source of transmission to humans and domestic animals. Despite successful attempts over the years to reduce the incidence of rabies, recent published reports indicate that in the U.S. more than 30,000 people undergo treatment for possible exposure. Domestic animals are the major source of exposure for humans. Since 1980, the most commonly reported rabid domestic animals have been cats, cattle and dogs. In 1990, a total of 4881 cases of animal rabies were reported to the Centers for Disease Control by all 50 states, the District of Columbia, and Puerto Rico. Susceptibility to rabies varies according to pet species. Rabies is not a treatable disease and suspect pets are usually quarantined until a clinical diagnosis is made, at which time they are destroyed.

The route of infection can be oral, respiratory, or parenteral. Following infection, a paralytic syndrome ensues, emerging as either the "furious" or "dumb" form. "Furious rabies" is characterized by unusual aggression; "dumb rabies" by lethargy and a desire to avoid contact. Respiratory failure is the immediate cause of death.

SAFETY AND EFFICACY: Because Defensor 3 is produced on an established cell line, it has safety advantages over inactivated brain-origin rabies vaccines. Tissue-origin vaccines contain extraneous protein in addition to rabies antigen that can lead to autoimmune disease.

The established cell line used in Defensor 3 has been extensively tested for freedom from contaminating agents. In addition, use of an established cell line yields a vaccine of consistent potency from serial to serial. Defensor 3 has proven to be uniformly safe in experimental tests, and no significant adverse reactions were reported in extensive clinical trials of the vaccine.

A duration-of-immunity study, conducted in accordance with federal regulation and under U/.S. Department of Agriculture directions, demonstrated that a 1-mL dose met federal guidelines for protection of dogs and cats against virulent challenge administered 3 years after vaccination. Cattle and sheep were likewise protected 1 year after receiving a 2-mL dose of Defensor 3.

Dogs and Cats:
1. General Directions: Shake well. Aseptically administer 1 mL subcutaneously. Dogs may be vaccinated intramuscularly or subcutaneously.
2. Primary Vaccination: Administer a single 1-mL dose at 3 months of age or older to healthy dogs and cats. A repeat dose should be administered 1 year later.
3. Revaccination: Subsequent revaccination every 3 years with a single dose is recommended.

Cattle and Sheep:
1. General Directions: Shake well. Aseptically administer 2 mL intramuscularly.
2. Primary Vaccination: Administer a single 2-mL dose at 3 months of age or older to healthy cattle and sheep. A repeat dose should be administered 1 year later.
3. Revaccination: Annual revaccination with a single dose is recommended.

1. Store at 2 degrees - 7 degrees C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
2. Use entire contents when first opened.
3. Sterilized syringes and needles should be used to administer this vaccine.
4. Do not vaccinate within 21 days of slaughter.
5. Contains gentamicin as preservative.
6. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
7. This product has been shown to be efficacious in healthy animals. A protective immune respone may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental coonditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

1. Kaplan MM, Korprowski H: Rabies, Austr Vet Pract 10:208-205, 1980
2. Uhaa IJ, Mandell EJ, Whiteway R, et al: Rabies surveillance in the United States during 1990, AM J Vet Med 200:920-929, 1992.

Technical inquiries should be directed to Pfizer Animal Health
Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada)

For veterinary use only

U.S. Veterinary License No. 189

Pfizer Animal Health
Exton, PA 19341, USA
Div. of Pfizer Inc
NY, NY 10017


Click image for larger version.